[BMRN] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[BMRN] BioMarin Pharmaceutical Inc.
Announcement Date
28-Oct-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -124.05%
YoY- 81.77%
Quarter Report
BMRN's Result
BMRN's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 733,867,000 585,965 505,344 408,742 476,784 461,097 391,706 250.70%
PBT 134,441,000 41,669 -1,904 -46,160 -61,216 9,822 -19,413 -
Tax 28,361,000 1,291 4,748 -9,666 -846,019 -45,214 -6,793 -
NP 106,080,000 40,378 -6,652 -36,494 784,803 55,036 -12,620 -
Tax Rate -21.10% -3.10% - - - 460.33% - -
Total Cost 627,787,000 545,587 511,996 445,236 -308,019 406,061 404,326 239.90%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 14.45 6.89 -1.32 -8.93 164.60 11.94 -3.22 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 557.06 0.21 -0.04 -0.20 4.33 0.31 -0.07 -
EPS Diluted 538.08 0.21 -0.04 -0.20 4.01 0.30 -0.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.